AMG-3969 is a potent small molecule disruptor of the glucokinase-glucokinase regulatory protein (GK-GKRP) interaction, exhibiting an IC50 of 4 nM. This tool compound is valuable for diabetes research, enabling the study of hepatic glucose metabolism in both cellular and animal models to explore potential therapeutic strategies.